Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

We found no significant association between catheter survival and other factors, including sex, age, BMI, hemodialysis vintage, catheter use duration, hypertension, diabetes mellitus, use of active vitamin D, phosphate binders, antiplatelet agents (dipyridamole, clopidogrel, aspirin), and rivaroxaban.

Source: Follow-up. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

All patients were diagnosed with central venous occlusion.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Treatment, characteristics and prognosis of central venous occlusion in hemodialysis patients with tunneled cuffed catheter dysfunction

Study design awaiting verification · Renal Failure · 2026

Original publication title

Treatment, characteristics and prognosis of central venous occlusion in hemodialysis patients with tunneled cuffed catheter dysfunction

Bohua Zhang; Lichao Zhong; Yuqin Xiong; Ruoxi Liao; Tianlei Cui

© 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Catheter exchange and endovascular treatment for central venous occlusion are safe and effective. Percutaneous superior vena cava puncture provides a valuable salvage option for this complex population, supporting durable long-term vascular access. Thrombosis and fibrin sheath predict poorer catheter survival.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Central venous occlusion (CVO) is a severe complication in hemodialysis patients with tunneled cuffed catheters (TCC), leading to catheter dysfunction and poor outcomes. Optimal treatment remains controversial.

Source: Background

Abstract: What methods does the paper describe?

This retrospective study included 123 hemodialysis patients with TCC dysfunction and CVO between February 2017 and December 2025. Patients underwent either exchange of the existing catheter or placement of a new catheter at a different venous site, with or without concurrent balloon angioplasty or stenting.

Source: Methods

Abstract: What is known

Central venous occlusion (CVO) is a severe complication in hemodialysis patients with tunneled cuffed catheters (TCC), leading to catheter dysfunction and poor outcomes.

Source: What is known

Abstract: What this study adds

In a cohort of 123 patients, catheter exchange with endovascular treatment achieved a median catheter survival of 735 days, with atrial thrombus and fibrin sheath identified as significant predictors of shorter survival.

Source: What this study adds

Abstract: Potential impact

This study supports catheter exchange with endovascular intervention as a safe and effective strategy, and highlights the direct superior vena cava puncture as a valuable salvage option when conventional access is exhausted.

Source: Potential impact

Abstract: Results

The cohort had a mean age of 61.02 ± 13.66 years, 29.2% male, with mean hemodialysis vintage of 7.86 years. Brachiocephalic vein occlusion was the most common lesion (74.8%), followed by superior vena cava occlusion (63.4%). Median catheter survival was 735 days. Recurrent dysfunction requiring reintervention occurred in 39.0% of patients (median time 255 days). Atrial thrombus (17.8%) and fibrin sheath (38.2%) were significantly associated with shorter catheter survival (p < 0.05). Most patients had reduced right ventricular basal diameter (98.0%) and increased left ventricular mass index (40.9%).

Source: Results

Abstract: Conclusions

Catheter exchange and endovascular treatment for central venous occlusion are safe and effective. Percutaneous superior vena cava puncture provides a valuable salvage option for this complex population, supporting durable long-term vascular access. Thrombosis and fibrin sheath predict poorer catheter survival.

Source: Conclusions
Authors’ abstract

Abstract

Background

Central venous occlusion (CVO) is a severe complication in hemodialysis patients with tunneled cuffed catheters (TCC), leading to catheter dysfunction and poor outcomes. Optimal treatment remains controversial.

Methods

This retrospective study included 123 hemodialysis patients with TCC dysfunction and CVO between February 2017 and December 2025. Patients underwent either exchange of the existing catheter or placement of a new catheter at a different venous site, with or without concurrent balloon angioplasty or stenting.

Results

The cohort had a mean age of 61.02 ± 13.66 years, 29.2% male, with mean hemodialysis vintage of 7.86 years. Brachiocephalic vein occlusion was the most common lesion (74.8%), followed by superior vena cava occlusion (63.4%). Median catheter survival was 735 days. Recurrent dysfunction requiring reintervention occurred in 39.0% of patients (median time 255 days). Atrial thrombus (17.8%) and fibrin sheath (38.2%) were significantly associated with shorter catheter survival (p < 0.05). Most patients had reduced right ventricular basal diameter (98.0%) and increased left ventricular mass index (40.9%).

Conclusions

Catheter exchange and endovascular treatment for central venous occlusion are safe and effective. Percutaneous superior vena cava puncture provides a valuable salvage option for this complex population, supporting durable long-term vascular access. Thrombosis and fibrin sheath predict poorer catheter survival.

LAY SUMMARY

For patients on long-term hemodialysis, a central venous catheter (a tube placed in a large vein) is sometimes necessary when other types of vascular access are not available. However, these catheters can cause a serious complication called central venous occlusion (CVO): a blockage in the large veins of the chest that prevents blood from flowing properly. This can lead to poor dialysis, swelling, low blood pressure, and may eventually make it impossible to continue hemodialysis treatment.

In this study, we reviewed 123 patients with CVO who underwent catheter exchange or replacement, often combined with balloon angioplasty to open the blocked vein. We found that the average time a catheter remained functional after treatment was 735 days (about 2 years). About 39% of patients needed additional intervention after a median of 255 days. The presence of blood clots in the heart or around the catheter tip was linked to shorter catheter survival.

Our study also showed that most patients had a smaller-than-normal right ventricle, while the left ventricle was often enlarged: a unique pattern that suggests the heart is affected by the vein blockage itself, rather than by fluid overload. This indicates that restoring blood flow through the blocked vein is more important than simply removing fluid by dialysis.

Overall, our findings suggest that catheter exchange with endovascular treatment is a safe and effective approach. For patients with no other options, puncturing the superior vena cava directly can serve as a valuable backup method. Recognizing and treating blood clots and fibrin sheaths early may help prolong catheter life and improve patient outcomes.

KEY MESSAGES (IMPACT STATEMENT)

What is known

Central venous occlusion (CVO) is a severe complication in hemodialysis patients with tunneled cuffed catheters (TCC), leading to catheter dysfunction and poor outcomes.

What this study adds

In a cohort of 123 patients, catheter exchange with endovascular treatment achieved a median catheter survival of 735 days, with atrial thrombus and fibrin sheath identified as significant predictors of shorter survival.

Potential impact

This study supports catheter exchange with endovascular intervention as a safe and effective strategy, and highlights the direct superior vena cava puncture as a valuable salvage option when conventional access is exhausted.

Publication and source details

Original title: Treatment, characteristics and prognosis of central venous occlusion in hemodialysis patients with tunneled cuffed catheter dysfunction

Bohua Zhang; Lichao Zhong; Yuqin Xiong; Ruoxi Liao; Tianlei Cui

Renal Failure · 2026

Supplemental data for this article can be accessed online at https://doi.org/10.1080/0886022X.2026.2732516.

CONTACT Ruoxi Liao lrx-scu@scu.edu.cnTianlei Cui tianleicui@163.com Department of Nephrology, West China Hospital of Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan 610041, China
© 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.2026The Author(s)https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:38:16.496370+00:00

DOI: 10.1080/0886022x.2026.2732516 · PMC13629761